Mylan will get DCGI nod for remdesivir in India

New Delhi, July 6 Pharmaceutical main Mylan NV on Monday stated it had obtained approval from Indian medication regulator DCGI to fabricate and market its remdesivir for restricted emergency use within the nation for the…